D. Inflammatory Bowel Disease

In this exclusive video, Bruce Sands, MD, MS, discusses Tremfya and Simponi yields higher rates of clinical response, remission and endoscopic improvements in moderate-to-severe ulcerative colitis.

In this Healio video series, which focuses on cultural competency in the treatment of inflammatory bowel disease, Neha D. Shah, MPH, RD, CNSC, CHES, discusses the food culture in South Asia and the associated challenges when treating IBD.

Patients with ulcerative colitis were more likely to respond to therapy if started on Entyvio within 30 days of diagnosis rather than if delayed by other initial treatments, according to a presenter at the Crohn’s and Colitis Congress.

A presenter at the Crohn’s and Colitis Congress discussed the latest research on COVID-19 in patients with inflammatory bowel disease.